Clinical Trials List
Protocol Number108760
2009-08-10 - 2010-12-25
Phase II
Terminated3
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 李敏雄 Division of Pediatrics
- 黃文嬋 Division of Pediatrics
- Chun-yi Lu Division of Pediatrics
- TING-YU YEN Division of Pediatrics
- 戴君芙 Division of Pediatrics
- Luan-Yin Chang Division of Pediatrics
- 莊佳韻 Division of Pediatrics
- 邵蓓嵐 Division of Pediatrics
- 陳威樺 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 胡人然 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 江椿彬 Division of Pediatrics
- 楊俊仁 Division of Pediatrics
- 陳偉燾 Division of Pediatrics
- Chi Hsin Division of Pediatrics
- Nan-Chang Chiu Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
249 participants
-
Global
498 participants
